Prognostic value of the S100B protein in newly diagnosed and recurrent glioma patients: a serial analysis. - Wikidata - awgldk - TriplyDB

Prognostic value of the S100B protein in newly diagnosed and recurrent glioma patients: a serial analysis.

Prognostic value of the S100B protein in newly diagnosed and recurrent glioma patients: a serial analysis.

http://www.wikidata.org/entity/Q37250446

about

S100A6 protein: functional roles.Association of S100B polymorphisms and serum S100B with risk of ischemic stroke in a Chinese population.

P2860

Q39247295-0D00A5C1-08D0-4899-A0C0-48B38F54B9F9 Q49539382-8C9D269F-8913-4932-BC8B-A61E4D3EF1AC

P2860

Prognostic value of the S100B protein in newly diagnosed and recurrent glioma patients: a serial analysis.

http://www.wikidata.org/entity/Q37250446

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 July 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Prognostic value of the S100B ...... a patients: a serial analysis.

@en

Prognostic value of the S100B ...... a patients: a serial analysis.

@nl

type

label

Prognostic value of the S100B ...... a patients: a serial analysis.

@en

Prognostic value of the S100B ...... a patients: a serial analysis.

@nl

prefLabel

Prognostic value of the S100B ...... a patients: a serial analysis.

@en

Prognostic value of the S100B ...... a patients: a serial analysis.

@nl

P1433

Q37250446-C4CE153B-ABBA-473B-B43A-747AC60AF8C2

P1476

Q37250446-17E21184-64E6-47C8-8A9D-36FA929D6237

P2093

Q37250446-0B7BC66F-F5FE-4A8D-A161-11A550EDD0FA

Q37250446-0D203279-7139-46E8-B9BD-1B93116EB0B7

Q37250446-0DD58123-9F44-453F-AE85-B314C2B6AD7D

Q37250446-114F7D1B-3724-408D-BA8F-EAEF1DE76AB0

Q37250446-21C023A6-3F88-4784-A2E2-096F92084809

Q37250446-2950AB5E-013F-451C-A102-2D240D5CA731

Q37250446-33E6E922-0CAE-4948-854F-EB20C3F399C0

Q37250446-5FC9BC29-632D-4DE0-9016-AEADB0ED338A

Q37250446-7AACD684-9A38-4378-98D7-81FB4C0B079E

Q37250446-D0940320-890C-4927-B97A-D8277DB5E2C4

P2860

Q37250446-01439ABC-7CF6-4AD4-994C-083DB745B792

Q37250446-0A74F9C7-314F-4836-AFDF-808C8C977AD3

Q37250446-0FE8E706-E92E-465B-AD5E-9F0A8A136B1E

Q37250446-105AA7D4-B34B-40A5-8397-A1B36FB8D0D7

Q37250446-1135FD3C-5DFB-4503-9FDD-2BF24E3DBA7A

Q37250446-21853475-A0F4-4C0F-B7C2-5676673903B3

Q37250446-21B930E9-CF0F-4126-8C69-6B4BA67AE443

Q37250446-255E3B2D-0870-4165-8B1D-D108E3CD0487

Q37250446-2BBEA036-15B5-49CB-86C0-2221EC645EC1

Q37250446-313FCA20-45EF-46C1-AC38-B4D57F42C7A9

P2888

Q37250446-F44EE365-0887-415E-84E3-579F54BEB432

P304

Q37250446-BB1A6165-73BB-4D0B-80DA-209E093935DC

P31

Q37250446-FF256657-542F-4AD5-B1D9-60506E58D23C

P356

Q37250446-D4596B11-594D-4C16-A57D-6866200BDABE

P433

Q37250446-10F7032F-B047-45C8-A3C9-36EA5166F25E

P478

Q37250446-5664C58B-A035-4548-9D29-8C3E54BBDB7F

P577

Q37250446-EFE0170B-729D-46DE-A445-CFD063F18A97

P698

Q37250446-EFC6FA30-B718-4ED5-AAF5-DECD19D443C6

P932

Q37250446-CDEAB76B-7FCA-4807-A714-54158CC14C7A

P356

S11060-016-2204-Z

P1433

Journal of Neuro-Oncology

P1476

Prognostic value of the S100B ...... a patients: a serial analysis.

@en

P2093

B M J Uitdehaag

http://www.w3.org/2001/XMLSchema#string

E M Sizoo

http://www.w3.org/2001/XMLSchema#string

F K Holla

http://www.w3.org/2001/XMLSchema#string

J Buter

http://www.w3.org/2001/XMLSchema#string

J C Reijneveld

http://www.w3.org/2001/XMLSchema#string

J J Heimans

http://www.w3.org/2001/XMLSchema#string

M A Blankenstein

http://www.w3.org/2001/XMLSchema#string

M J Vos

http://www.w3.org/2001/XMLSchema#string

M Klein

http://www.w3.org/2001/XMLSchema#string

M de Groot

http://www.w3.org/2001/XMLSchema#string

P2860

The 2007 WHO classification of tumours of the central nervous system

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

S100B protein in myoblasts modulates myogenic differentiation via NF-kappaB-dependent inhibition of MyoD expression

Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions

Immunochemical and immuno-cytochemical localization of S-100 antigen in normal human skin.

Peripheral markers of blood-brain barrier damage.

Predictive value of S-100β protein for prognosis in patients with moderate and severe traumatic brain injury: systematic review and meta-analysis.

Survival and prognostic factors of anaplastic gliomas.

Use of S-100B to evaluate therapy effects during bevacizumab induction treatment in AJCC stage III melanoma.

P2888

s11060-016-2204-z

P304

525-532

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11060-016-2204-Z

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

129

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27401156

http://www.w3.org/2001/XMLSchema#string

P932

5020117

http://www.w3.org/2001/XMLSchema#string